RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA T. Calimeri, K. Cwynarski, E. Pulczynski, C. P. Fox,E. Schorb, S. Steffanoni, M. Foppoli, C. Celico, M. Falautano, A. Nonis,P. La Rosee, M. Binder, A. Fabbri,F. Ilariucci,M. Krampera,A. Roth, C. Hemmaway, P. W. Johnson, K. M. Linton, T. Pukrop,J. Sonderskov Gorlov,M. Balzarotti,G. Hess,U. Keller,S. Stilgenbauer, J. Panse, A. Tucci,L. Orsucci,F. Pisani,M. Zanni, S. W. Krause,H. J. Schmoll,B. Hertenstein, M. Rummel,J. Smith, L. Thurner, G. Cabras, E. Pennese,M. Ponzoni, M. Deckert, L. S. Politi,J. Finke, A. Ferranti, K. Cozens, E. Burger, N. Ielmini, F. Cavalli,E. Zucca,G. Illerhaus, A. J. M. FerreriHAEMATOLOGICA（2021）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
